Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Stress exacerbates experimental Parkinson's disease.

Hemmerle AM, Dickerson JW, Herman JP, Seroogy KB.

Mol Psychiatry. 2014 Jun;19(6):638-40. doi: 10.1038/mp.2013.108. Epub 2013 Sep 3. No abstract available.

PMID:
23999522
2.

High frequency stimulation of the subthalamic nucleus improves speed of locomotion but impairs forelimb movement in Parkinsonian rats.

Vlamings R, Visser-Vandewalle V, Koopmans G, Joosten EA, Kozan R, Kaplan S, Steinbusch HW, Temel Y.

Neuroscience. 2007 Sep 7;148(3):815-23. Epub 2007 Jul 17.

PMID:
17706885
3.

High frequency stimulation of subthalamic nucleus results in behavioral recovery by increasing striatal dopamine release in 6-hydroxydopamine lesioned rat.

He Z, Jiang Y, Xu H, Jiang H, Jia W, Sun P, Xie J.

Behav Brain Res. 2014 Apr 15;263:108-14. doi: 10.1016/j.bbr.2014.01.014. Epub 2014 Jan 23.

PMID:
24462728
4.

A time-course study of behavioral and electrophysiological characteristics in a mouse model of different stages of Parkinson's disease using 6-hydroxydopamine.

Park SE, Song KI, Suh JK, Hwang D, Youn I.

Behav Brain Res. 2015 May 1;284:153-7. doi: 10.1016/j.bbr.2015.02.019. Epub 2015 Feb 16.

PMID:
25698596
5.

Forced nonuse in unilateral parkinsonian rats exacerbates injury.

Tillerson JL, Cohen AD, Caudle WM, Zigmond MJ, Schallert T, Miller GW.

J Neurosci. 2002 Aug 1;22(15):6790-9.

7.

Effect of exercise on dopamine neuron survival in prenatally stressed rats.

Mabandla MV, Kellaway LA, Daniels WM, Russell VA.

Metab Brain Dis. 2009 Dec;24(4):525-39. doi: 10.1007/s11011-009-9161-6. Epub 2009 Oct 21.

8.

NAIP protects the nigrostriatal dopamine pathway in an intrastriatal 6-OHDA rat model of Parkinson's disease.

Crocker SJ, Wigle N, Liston P, Thompson CS, Lee CJ, Xu D, Roy S, Nicholson DW, Park DS, MacKenzie A, Korneluk RG, Robertson GS.

Eur J Neurosci. 2001 Jul;14(2):391-400.

PMID:
11553289
9.

Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.

Chaturvedi RK, Shukla S, Seth K, Chauhan S, Sinha C, Shukla Y, Agrawal AK.

Neurobiol Dis. 2006 May;22(2):421-34. Epub 2006 Feb 9.

PMID:
16480889
10.

NF-kappaB contributes to 6-hydroxydopamine-induced apoptosis of nigral dopaminergic neurons through p53.

Liang ZQ, Li YL, Zhao XL, Han R, Wang XX, Wang Y, Chase TN, Bennett MC, Qin ZH.

Brain Res. 2007 May 11;1145:190-203. Epub 2007 Feb 7.

PMID:
17368433
11.

Delivery of a GDNF gene into the substantia nigra after a progressive 6-OHDA lesion maintains functional nigrostriatal connections.

Kozlowski DA, Connor B, Tillerson JL, Schallert T, Bohn MC.

Exp Neurol. 2000 Nov;166(1):1-15.

PMID:
11031079
12.

Running wheel exercise enhances recovery from nigrostriatal dopamine injury without inducing neuroprotection.

O'Dell SJ, Gross NB, Fricks AN, Casiano BD, Nguyen TB, Marshall JF.

Neuroscience. 2007 Feb 9;144(3):1141-51. Epub 2006 Dec 8.

PMID:
17157992
13.

KDI tripeptide of gamma1 laminin protects rat dopaminergic neurons from 6-OHDA induced toxicity.

Väänänen AJ, Rauhala P, Tuominen RK, Liesi P.

J Neurosci Res. 2006 Aug 15;84(3):655-65.

PMID:
16810683
14.

Stress reduces the neuroprotective effect of exercise in a rat model for Parkinson's disease.

Howells FM, Russell VA, Mabandla MV, Kellaway LA.

Behav Brain Res. 2005 Dec 7;165(2):210-20. Epub 2005 Sep 12.

PMID:
16159673
15.

Neuroprotection in Parkinson models varies with toxin administration protocol.

Anderson DW, Bradbury KA, Schneider JS.

Eur J Neurosci. 2006 Dec;24(11):3174-82.

PMID:
17156378
16.

Environmental enrichment in adulthood eliminates neuronal death in experimental Parkinsonism.

Faherty CJ, Raviie Shepherd K, Herasimtschuk A, Smeyne RJ.

Brain Res Mol Brain Res. 2005 Mar 24;134(1):170-9.

PMID:
15790541
17.

Colchicine protects dopaminergic neurons in a rat model of Parkinson's disease.

Salama M, Ellaithy A, Helmy B, El-Gamal M, Tantawy D, Mohamed M, Sheashaa H, Sobh M, Arias-Carrión O.

CNS Neurol Disord Drug Targets. 2012 Nov 1;11(7):836-43.

PMID:
23198691
18.

Acetylcorynoline attenuates dopaminergic neuron degeneration and α-synuclein aggregation in animal models of Parkinson's disease.

Fu RH, Wang YC, Chen CS, Tsai RT, Liu SP, Chang WL, Lin HL, Lu CH, Wei JR, Wang ZW, Shyu WC, Lin SZ.

Neuropharmacology. 2014 Jul;82:108-20. doi: 10.1016/j.neuropharm.2013.08.007. Epub 2013 Aug 21.

PMID:
23973292
19.

[The reduced antioxidation ability in the serum in the early Parkinson's disease rats].

Peng Y, Yin SM, Yu DQ, Xu H, Dong FY, Tang J, Sun YP, Zhang WQ.

Zhongguo Ying Yong Sheng Li Xue Za Zhi. 2011 May;27(2):218-20. Chinese. No abstract available.

PMID:
21845878
20.

Differential effects on forelimb grasping behavior induced by fetal dopaminergic grafts in hemiparkinsonian rats.

Klein A, Metz GA, Papazoglou A, Nikkhah G.

Neurobiol Dis. 2007 Jul;27(1):24-35. Epub 2007 Apr 5.

PMID:
17512748
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk